These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2483564)

  • 21. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The renin-angiotensin system and large arteries in the hypertensive patient].
    Bouthier J; Hugue C; Asmar R; Simon A; Safar M
    Ann Cardiol Angeiol (Paris); 1985 Dec; 34(10):693-6. PubMed ID: 3004317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapy.
    Zusman RM
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):200S-206S. PubMed ID: 2568846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of amlodipine on cerebral circulatory values in patients with essential hypertension.
    Alizade IG; Karayeva NT
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):14-6. PubMed ID: 12122965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium channel blockers in the treatment of arterial hypertension].
    Kabat M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1456-9. PubMed ID: 2421275
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
    Safar ME; Laurent SL; Bouthier JD; London GM; Mimran AR
    J Hypertens Suppl; 1986 Dec; 4(5):S285-9. PubMed ID: 3033179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the arterial blood pressure and nonhemodynamic factors on regional arterial wall properties in moderate essential hypertension.
    Duprez DA; De Buyzere ML; Verloove HH; Kaufman JM; Van Hoecke MJ; Clement DL
    J Hum Hypertens; 1996 Apr; 10(4):251-6. PubMed ID: 8736457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial stiffening and vascular/ventricular interaction.
    O'Rourke M
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S9-15. PubMed ID: 7807513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are calcium antagonists the best option in elderly hypertensives?
    Forette F; Bert P; Rigaud AS
    J Hypertens Suppl; 1994 Sep; 12(6):S19-23. PubMed ID: 7799105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial compliance is not diminished in hypertensive patients when compared at the same level of blood pressure].
    Laurent S; Lacolley P; Girerd X; Caviezel B; Beck L; Challande P; Safar M
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1069-72. PubMed ID: 7755461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac hypertrophy and aortic compliance after calcium channel antagonism in hypertension.
    Pannier BM; Tual JL; Safar ME
    Drugs; 1992; 44 Suppl 1():44-7. PubMed ID: 1283583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilatation of small and large arteries in hypertension.
    Levenson JA; Simon AC; Safar ME
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S115-20. PubMed ID: 2409359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium channel blockers in the treatment of arterial hypertension].
    Rorive G
    Rev Med Liege; 1996 Jan; 51(1):24-6. PubMed ID: 8701131
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcium channel blockers associated with less diabetes.
    Mayor S
    BMJ; 2006 Sep; 333(7567):514. PubMed ID: 16960195
    [No Abstract]   [Full Text] [Related]  

  • 38. New trends in anti-hypertensive therapy, calcium channel entry blockers.
    Ishaq M
    J Pak Med Assoc; 1988 Oct; 38(10):275-9. PubMed ID: 3144610
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium channel blockers provide significant benefit in hypertension, says a WHO-ISH analysis.
    Cardiovasc J S Afr; 2001; 12(1):52. PubMed ID: 11474685
    [No Abstract]   [Full Text] [Related]  

  • 40. Preservation of renal function: the spectrum of effects by calcium channel blockers.
    Deray G
    Nephrol Dial Transplant; 1998 May; 13(5):1315-6. PubMed ID: 9623579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.